This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (78)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Oncology, Other  • Randomized Controlled Trial  • Alert me on articles by topic  Social Bookmarking   What's this?

A Prospective Randomized Study

Metin Senkal, MD; Volker Zumtobel, MD; Karl-Heinz Bauer, MD; Barbara Marpe, MD; Günther Wolfram, MD; Andreas Frei, MPH; Ulrich Eickhoff, MD; Matthias Kemen, MD

Arch Surg. 1999;134:1309-1316.

Hypothesis  Perioperatively administered enteral immunonutrition will improve early postoperative morbidity and cost-effectiveness after gastrointestinal tract surgery.

Design  A prospective, randomized, double-blind, multicenter clinical trial.

Setting  Surgical departments in German university and teaching hospitals.

Patients  One hundred fifty-four patients with upper gastrointestinal tract malignant neoplasms who were eligible for analysis.

Intervention  Preoperatively, patients received 5 days of oral immunonutrition (an arginine-, RNA-, and 3 fatty acid–supplemented diet) or an isoenergetic control diet (1 L/d). Early postoperative enteral feeding with immunonutrition or an isoenergetic, isonitrogenous control diet using a catheter jejunostomy was performed for 10 days.

Main Outcome Measures  Postoperative infectious complications, their treatment costs, and cost-effectiveness of immunonutrition were analyzed. Plasma levels of the fatty acids eicosapentaenoic acid and docosahexaenoic acid were measured.

Results  In the immunonutrition group, significantly fewer infectious complication events occurred (14 vs 27; P = .05). The number of patients with complications was significantly lower in the supplemented diet group after postoperative day 3 (7 vs 16; P = .04). The treatment costs of complications in the supplemented diet group were suggestively lower than in the control diet group (DM 75 172 vs DM 204 273). Cost-effectiveness was DM 1503 in the experimental group vs DM 3587 in the control group, where DM denotes deutsche mark (German currency).

Conclusion  The perioperative administration of an enteral immunonutrition significantly (P = .05) decreased the early occurrence of postoperative infections and reduced substantially the treatment costs of the complications after major upper gastrointestinal tract surgery.

From the Department of Surgery, Ruhr-University Bochum, St Josef Hospital, Bochum, Germany (Drs Senkal, Zumtobel, Bauer, and Marpe); the Department of Nutritional Sciences, Technical University Munich, Freising/ Weihenstephan, Germany (Dr Wolfram); HealthEcon AG, Basel, Switzerland (Mr Frei); and the Department of Surgery, Evangelisches Krankenhaus Herne, Herne, Germany (Drs Eickhoff and Kemen).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A.S.P.E.N. Clinical Guidelines: Nutrition Support Therapy During Adult Anticancer Treatment and in Hematopoietic Cell Transplantation
August et al.
JPEN J Parenter Enteral Nutr 2009;33:472-500.
FULL TEXT  

Cost Effectiveness of Natural Health Products: A Systematic Review of Randomized Clinical Trials
Kennedy et al.
Evid Based Complement Alternat Med 2009;6:297-304.
ABSTRACT | FULL TEXT  

Arginine in the Critical Care Setting
Zhou and Martindale
J. Nutr. 2007;137:1687S-1692S.
ABSTRACT | FULL TEXT  

Nutrition Support in Adult Trauma Patients
Todd et al.
Nutr Clin Pract 2006;21:421-429.
ABSTRACT | FULL TEXT  

Effects of Omega-3 Fatty Acids on Cancer Risk: A Systematic Review
MacLean et al.
JAMA 2006;295:403-415.
ABSTRACT | FULL TEXT  

Enteral Nutrition and Oral Nutrition Supplements: A Review of the Economics Literature
Pritchard et al.
JPEN J Parenter Enteral Nutr 2006;30:52-59.
ABSTRACT | FULL TEXT  

Appropriate Use of Artificial Nutrition and Hydration -- Fundamental Principles and Recommendations
Casarett et al.
NEJM 2005;353:2607-2612.
FULL TEXT  

Immunonutrition and Upper Gastrointestinal Surgery: What Really Matters
Sax
Nutr Clin Pract 2005;20:540-543.
ABSTRACT | FULL TEXT  

Preoperative Immunonutrition: Cost-Benefit Analysis
Braga and Gianotti
JPEN J Parenter Enteral Nutr 2005;29:S57-S61.
ABSTRACT | FULL TEXT  

Reducing Costs and Patient Morbidity in the Enterally Fed Intensive Care Unit Patient
Farber et al.
JPEN J Parenter Enteral Nutr 2005;29:S62-S69.
ABSTRACT | FULL TEXT  

Is the Use of Specialized Nutritional Formulations a Cost-Effective Strategy? A National Database Evaluation
Strickland et al.
JPEN J Parenter Enteral Nutr 2005;29:S81-S91.
ABSTRACT | FULL TEXT  

Targeting the Use of Specialized Nutritional Formulas in Surgery and Critical Care
Cresci
JPEN J Parenter Enteral Nutr 2005;29:S92-S95.
FULL TEXT  

Role of Omega-3 Fatty Acid Supplementation in Inflammation and Malignancy
Jho et al.
Integr Cancer Ther 2004;3:98-111.
ABSTRACT  

Arginine Immunonutrition in Critically Ill Patients: A Clinical Dilemma
Stechmiller et al.
Am J Crit Care 2004;13:17-23.
ABSTRACT | FULL TEXT  

Immunonutrition: problematic or problem solving?
McCowen and Bistrian
Am. J. Clin. Nutr. 2003;77:764-770.
ABSTRACT | FULL TEXT  

Protective nutrients and functional foods for the gastrointestinal tract
Duggan et al.
Am. J. Clin. Nutr. 2002;75:789-808.
ABSTRACT | FULL TEXT  

Nutritional Approach in Malnourished Surgical Patients: A Prospective Randomized Study
Braga et al.
Arch Surg 2002;137:174-180.
ABSTRACT | FULL TEXT  

Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients
American Society for Parenteral and Enteral Nutrit
JPEN J Parenter Enteral Nutr 2002;26:1SA-138SA.
 

Early Enteral Nutrition in Critically III Patients With a High-Protein Diet Enriched with Arginine, Fiber, and Antioxidants Compared With a Standard High-Protein Diet. The Effect on Nosocomial Infections and Outcome
Caparros et al.
JPEN J Parenter Enteral Nutr 2001;25:299-309.
ABSTRACT  

Should Immunonutrition Become Routine in Critically Ill Patients?: A Systematic Review of the Evidence
Heyland et al.
JAMA 2001;286:944-953.
ABSTRACT | FULL TEXT  

Introduction
Kudsk
JPEN J Parenter Enteral Nutr 2001;25:S1-S2.
 

Immune-Enhancing Diets: Products, Components, and Their Rationales
Schloerb
JPEN J Parenter Enteral Nutr 2001;25:S3-S7.
 

Effect of Immune Enhancing Formulas (IEF) in General Surgery Patients
Sax
JPEN J Parenter Enteral Nutr 2001;25:S19-S23.
 

Effects of Immune-Enhancing Diets on Infectious Morbidity and Multiple Organ Failure
Moore
JPEN J Parenter Enteral Nutr 2001;25:S36-S43.
 

The Effects of Immune-Enhancing Diets (IEDs) on Mortality, Hospital Length of Stay, Duration of Mechanical Ventilation, and Other Parameters
McClave
JPEN J Parenter Enteral Nutr 2001;25:S44-S50.
 

Response to Dr Buchman
Gianotti
JPEN J Parenter Enteral Nutr 2000;24:367-368.